Basics NewAmsterdam Pharma Company IPO Date: February 9, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.91B Activated in VL: True Average Daily Range Avg Daily Range: $0.43 | 2.73% Avg Daily Range (30 D): $0.38 | 2.06% Avg Daily Range (90 D): $0.52 | 2.65% Institutional Daily Volume Avg Daily Volume: .29M Avg Daily Volume (30 D): .53M Avg Daily Volume (90 D): .81M Trade Size Avg Trade Size (Sh.): 99 Avg Trade Size (Sh.) (30 D): 76 Avg Trade Size (Sh.) (90 D): 89 Institutional Trades Total Inst.Trades: 498 Avg Inst. Trade: $1.46M Avg Inst. Trade (30 D): $1.05M Avg Inst. Trade (90 D): $1.34M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.24M Avg Closing Trade (30 D): $1.01M Avg Closing Trade (90 D): $1.07M Avg Closing Volume: 58.97K         News Jan 9, 2025 @ 8:38 PM NewAmsterdam Pharma Reports Inducement Grants Unde... Source: N/A Dec 13, 2024 @ 10:16 PM NewAmsterdam Pharma Announces Closing of Upsized $... Source: N/A Dec 12, 2024 @ 2:37 AM NewAmsterdam Pharma Announces Pricing of Upsized $... Source: N/A Dec 10, 2024 @ 9:34 PM NewAmsterdam Pharma Announces Commencement of $300... Source: N/A Dec 10, 2024 @ 12:00 PM NewAmsterdam Pharma Announces Positive Topline Dat... Source: Newamsterdam Pharma Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.84 $-.34 $-.95 Diluted EPS $-1.84 $-.34 $-.95 Revenue $ 47.14M $ 2.98M $ 12.77M Gross Profit $ $ $ Net Income / Loss $ -187.36M $ -39.53M $ -92.18M Operating Income / Loss $ -189.73M $ -68.93M $ -43.23M Cost of Revenue $ $ $ Net Cash Flow $ 267.81M $ -27.09M $ 356.95M PE Ratio